Felix S Lichtenegger

4PUBLICATIONS
13CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 25, 2026
Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial.

|Nov 25, 2021
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.

Gerulf Hänel, Caroline Angerer, Katja Petry

|May 01, 2019
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.

Heleen H Van Acker, Maarten Versteven, Felix S Lichtenegger

|Aug 24, 2017
Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.

Thomas Köhnke, Veronika K Wittmann, Veit L Bücklein

Pageof 1

Frequent Collaborators

2 joint publications

Marion Subklewe

1 joint publications

Thomas Köhnke

1 joint publications

Gils Roex

1 joint publications

Eva Lion